Provided by Tiger Trade Technology Pte. Ltd.

Jazz Pharmaceuticals PLC

231.19
-0.2000-0.09%
Pre-market: 229.85-1.3400-0.58%04:15 EDT
Volume:578.91K
Turnover:134.40M
Market Cap:15.01B
PE:15.80
High:235.54
Open:229.62
Low:227.00
Close:231.39
52wk High:266.38
52wk Low:128.80
Shares:64.91M
Float Shares:62.69M
Volume Ratio:0.71
T/O Rate:0.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):14.63
EPS(LYR):-5.8403
ROE:22.11%
ROA:6.86%
PB:3.13
PE(LYR):-39.59

Loading ...

Nov 21, 2024

Major Issues Report

Form 8-K - Current report
Nov 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2024

Major Issues Report

Form 8-K - Current report
Nov 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 16, 2024

Major Issues Report

Form 8-K - Current report
Sep 06, 2024

Major Issues Report

Form 8-K - Current report
Sep 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 28, 2024

Major Issues Report

Form 8-K - Current report
Aug 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 01, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 31, 2024

Major Issues Report

Form 8-K - Current report
Jul 26, 2024

Major Issues Report

Form 8-K - Current report